{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T13:00:34Z","timestamp":1649163634171},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.encep.2007.12.003","type":"journal-article","created":{"date-parts":[[2008,2,22]],"date-time":"2008-02-22T16:25:11Z","timestamp":1203697511000},"page":"82-92","source":"Crossref","is-referenced-by-count":2,"title":["Donn\u00e9es actuelles et modalit\u00e9s d\u2019utilisation de l\u2019aripiprazole dans le traitement de la schizophr\u00e9nie"],"prefix":"10.1016","volume":"34","author":[{"given":"F.","family":"Limosin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Azorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.O.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Millet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Glikman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Camus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Crocq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Costentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dal\u00e9ry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.encep.2007.12.003_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/01.jcp.0000246206.65411.f5","article-title":"Clozapine augmented with aripiprazole in 5 patients with schizophrenia","volume":"26","author":"Abu-Tair","year":"2006","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.encep.2007.12.003_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/cap.2004.14.593","article-title":"The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review","volume":"14","author":"Barzman","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"10.1016\/j.encep.2007.12.003_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.jcp.0000169419.38899.5b","article-title":"Aripiprazole in schizophrenia with cocaine dependence: a pilot study","volume":"25","author":"Beresford","year":"2005","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.encep.2007.12.003_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S1092852900019489","article-title":"Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review","volume":"10","author":"Biederman","year":"2005","journal-title":"CNS Spectr"},{"issue":"6","key":"10.1016\/j.encep.2007.12.003_bib5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.v66n0613","article-title":"Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole","volume":"66","author":"Brown","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"10.1016\/j.encep.2007.12.003_bib6","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1345\/aph.1H240","article-title":"Efficacy with high-dose aripiprazole after olanzapine-related metabolic disturbances","volume":"40","author":"Chavez","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.encep.2007.12.003_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00213-006-0564-3","article-title":"Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52 \u2013 week, open-label comparison with olanzapine","volume":"189","author":"Chrzanowski","year":"2006","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.encep.2007.12.003_bib8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1080\/j.1440-1614.2005.01688_2.x","article-title":"Combination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophrenia","volume":"39","author":"Clarke","year":"2005","journal-title":"Aust NZJ Psychiatry"},{"issue":"5","key":"10.1016\/j.encep.2007.12.003_bib9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.pnpbp.2005.04.005","article-title":"High vulnerability to acute dystonic reactions: a case of antipsychotic exposure and uncontrolled seizure activity","volume":"29","author":"Coffey","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"7","key":"10.1016\/j.encep.2007.12.003_bib10","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.4088\/JCP.v67n0721d","article-title":"Tolerability of high-dose aripiprazole in treatment-refractory schizophrenic patients","volume":"67","author":"Crossman","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.encep.2007.12.003_bib11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1017\/S1092852900014784","article-title":"The efficacy and safety of lower doses of aripiprazole for the treatment of patients with acute exacrebation of schizophrenia","volume":"11","author":"Cutler","year":"2006","journal-title":"CNS Spectr"},{"issue":"5","key":"10.1016\/j.encep.2007.12.003_bib12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.biopsych.2006.04.010","article-title":"Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse","volume":"61","author":"Feltenstein","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.encep.2007.12.003_bib13","series-title":"ECDEU Assessment Manual for Psychopharmacology. US Depet Health, Educationand Welfare publication (ADM) 76-338","article-title":"Clinical Global Impressions","author":"Guy","year":"1976"},{"key":"10.1016\/j.encep.2007.12.003_bib14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0447.2005.00612.x","article-title":"An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia","volume":"113","author":"Henderson","year":"2006","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"10.1016\/j.encep.2007.12.003_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/alcalc\/agl037","article-title":"Effects of aripiprazole on alcohol intake in an animal model of high-alcohol drinking","volume":"41","author":"Ingman","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.encep.2007.12.003_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4088\/JCP.v63n0903","article-title":"Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder","volume":"63","author":"Kane","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2007.12.003_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4088\/JCP.v68n0206","article-title":"Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine","volume":"68","author":"Kane","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.12.003_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S1461145703003651","article-title":"Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia","volume":"6","author":"Kasper","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.encep.2007.12.003_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"issue":"9","key":"10.1016\/j.encep.2007.12.003_bib20","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.12.003_bib21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00213-006-0428-x","article-title":"The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine","volume":"187","author":"Kern","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.encep.2007.12.003_bib22","doi-asserted-by":"crossref","unstructured":"Kerwin R, Millet B, Herman E, Banki CM, Lublin M. A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients. Schizophrenia Trial of Aripiprazole (STAR) Study. Eur Psychiatry 2007;22:433\u201343.","DOI":"10.1016\/j.eurpsy.2007.03.002"},{"issue":"4","key":"10.1016\/j.encep.2007.12.003_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00023210-200418040-00005","article-title":"Dopamine partial agonists: a new class of antipsychotic","volume":"18","author":"Lieberman","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.encep.2007.12.003_bib24","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.4088\/JCP.v65n0918d","article-title":"Possible increased efficacy of low-dose clozapine when combined with aripiprazole","author":"Lim","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.encep.2007.12.003_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0920-9964(03)00050-1","article-title":"Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials","volume":"61","author":"Marder","year":"2003","journal-title":"Schizophr Res"},{"issue":"suppl 18","key":"10.1016\/j.encep.2007.12.003_bib26","first-page":"47","article-title":"A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study","volume":"65","author":"McQuade","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.12.003_bib27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpsychires.2007.05.002","article-title":"A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20mg\/day for the treatment of patients with acute exacerbations of schizophrenia","volume":"41","author":"McEvoy","year":"2007","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.encep.2007.12.003_bib28","unstructured":"Mitsonis CI, Dimopoulos NP, Mitropoulos PA et al. Aripiprazole augmentation in the management of residual symptoms in clozapine- treated outpatients with chronic schizophrenia: an open-label pilot study. Prog Neuropsychopharmacol Biol Psychiatry 2006 Nov 6."},{"key":"10.1016\/j.encep.2007.12.003_bib29","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.4088\/JCP.v64n0910","article-title":"Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controled 26 \u2013 week study","volume":"64","author":"Pigott","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.12.003_bib30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.60.7.681","article-title":"An antipsychotic with a novel mechanism of action, and risperidone versus placebo in patients with schizophrenia or schizoaffective disorder","volume":"60","author":"Potkin","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.encep.2007.12.003_bib31","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.pnpbp.2006.03.024","article-title":"Benefits of combining aripiprazole to clozapine: three case reports","volume":"30","author":"Rocha","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.encep.2007.12.003_bib32","first-page":"21121","article-title":"Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder","volume":"136","author":"Tandon","year":"2005","journal-title":"Psychiatry Res"},{"issue":"4","key":"10.1016\/j.encep.2007.12.003_bib33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1089\/cap.2006.16.498","article-title":"Advanced pediatric psychopharmacology","volume":"16","author":"Vito","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"11","key":"10.1016\/j.encep.2007.12.003_bib34","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4088\/JCP.v66n1103","article-title":"Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studies","volume":"66","author":"Volavka","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.encep.2007.12.003_bib35","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1080\/j.1440-1614.2005.01688_2.x","article-title":"Combination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophrenia","volume":"39","author":"Ziegenbein","year":"2005","journal-title":"Aust NZJ Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2007.12.003_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00044011-200626030-00001","article-title":"Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation","volume":"26","author":"Ziegenbein","year":"2006","journal-title":"Clin Drug Invest"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700607001558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700607001558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T06:58:41Z","timestamp":1557298721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700607001558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0013700607001558"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2007.12.003","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}